17α-spirolactone
17α-Spirolactone[edit | edit source]
17α-Spirolactone is a chemical compound that belongs to the class of steroids. It is a derivative of spironolactone, which is a well-known potassium-sparing diuretic and aldosterone antagonist. 17α-Spirolactone is primarily studied for its role as a metabolite of spironolactone and its potential biological activities.
Chemical Structure and Properties[edit | edit source]
17α-Spirolactone is characterized by the presence of a spirolactone ring, which is a cyclic ester formed by the linkage of a lactone group to the steroid backbone. This structural feature is crucial for its biological activity. The compound is a white to off-white crystalline powder, and it is relatively insoluble in water but soluble in organic solvents such as ethanol and chloroform.
Biological Activity[edit | edit source]
As a metabolite of spironolactone, 17α-spirolactone retains some of the pharmacological properties of its parent compound. It acts as an antagonist of the mineralocorticoid receptor, thereby inhibiting the effects of aldosterone. This action contributes to its diuretic and antihypertensive effects. Additionally, 17α-spirolactone may exhibit anti-androgenic properties, similar to spironolactone, which can be useful in the treatment of conditions like hirsutism and acne in females.
Pharmacokinetics[edit | edit source]
The pharmacokinetics of 17α-spirolactone are closely related to those of spironolactone. After oral administration of spironolactone, it undergoes extensive hepatic metabolism, resulting in the formation of several active metabolites, including 17α-spirolactone. These metabolites contribute to the overall therapeutic effects of spironolactone. The half-life of 17α-spirolactone is relatively short, and it is excreted primarily via the kidneys.
Clinical Significance[edit | edit source]
While 17α-spirolactone itself is not used as a therapeutic agent, its role as a metabolite of spironolactone is significant in understanding the drug's mechanism of action and its effects in the body. The study of 17α-spirolactone and other metabolites helps in optimizing the use of spironolactone in clinical practice, particularly in managing conditions like heart failure, hypertension, and hyperaldosteronism.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
